Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease.
Chronic rhinosinusitis has been shown to have an adverse impact on the quality of life in those afflicted as determined by a number of standardized outcome tools. We have utilized a standardized, statistically validated, disease-specific tool, the Rhinosinusitis Disability Index (RSDI), to investigate the disability suffered by 292 consecutive patients with nine unique rhinologic diagnoses, including chronic rhinosinusitis. Physical, functional, and emotional domains were assessed. We have found that individuals with rhinologic disease in general have lower physical scores, followed by functional scores and emotional scores. Individuals with chronic rhinosinusitis and allergic rhinitis have the greatest level of disability, while those with aspirin triad are least affected.
Henry Ford Hospital, Detroit, Michigan, USA.
B A
BA
Senior
C
C
Glaze
M S
MS
Benninger
D000203:Activities of Daily Living; D000328:Adult; D001241:Aspirin / Q000009:adverse effects; D002908:Chronic Disease; D006233:Persons with Disabilities / Q000145:classification*; D004342:Drug Hypersensitivity / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010036:Otolaryngology / Q000379:methods* / Q000592:standards; D017063:Outcome Assessment, Health Care; D011788:Quality of Life; D012220:Rhinitis / Q000145:classification* / Q000150:complications / Q000503:physiopathology / Q000523:psychology; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012852:Sinusitis / Q000145:classification* / Q000150:complications / Q000503:physiopathology / Q000523:psychology
D001241:Aspirin